Gilad Landan
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 2
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 4
- Genomics and Chromatin Dynamics 3
- Pluripotent Stem Cells Research 2
- CRISPR and Genetic Engineering 2
- RNA Research and Splicing 2
- Genetics top 10%
-
- Hematopoietic Stem Cell Transplantation 3
-
- T-cell and B-cell Immunology 2
- Co-authors
- Amos TanayZohar MukamelNetta Mendelson CohenVarda RotterNaomi GoldfingerRan BroshSjoerd J.B. HolwerdaChristian Valdes‐Quezada
- Partner nations
- United StatesIsraelGermany
In The Last Decade
Gilad Landan
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Cancer Research 257
- Molecular Biology 875
- Genetics 209
- Hematology 69
- Immunology 109
Countries citing papers authored by Gilad Landan
This map shows the geographic impact of Gilad Landan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad Landan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad Landan more than expected).
Fields of papers citing papers by Gilad Landan
This network shows the impact of papers produced by Gilad Landan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad Landan. The network helps show where Gilad Landan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gilad Landan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 56 | |
| 2 | 2014 | 113 | |
| 3 | 2014 | 33 | |
| 4 | 2012 | 272 | |
| 5 | 2012 | 205 | |
| 6 | 2009 | 12 | |
| 7 | 2009 | 174 | |
| 8 | 2008 | 132 | |
| 9 | Alloreactive T-cell trafficking after hematopoietic stem cell transplantation. | 2007 | 1 |
| 10 | 2007 | 87 | |
| 11 | 2006 | 1 | |
| 12 | 2005 | 2 |
About Gilad Landan
Gilad Landan is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Genomics and Chromatin Dynamics (3 papers), Pluripotent Stem Cells Research (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer-related molecular mechanisms research (2 papers), T-cell and B-cell Immunology (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (257 citations), Molecular Biology (875 citations) and Genetics (209 citations). Gilad Landan has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Amos Tanay, Zohar Mukamel, Netta Mendelson Cohen, Varda Rotter, Naomi Goldfinger, Ran Brosh, Sjoerd J.B. Holwerda, Christian Valdes‐Quezada, Michael Hoichman and Elzo de Wit.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.